Company: TVRD
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001104659-25-111289
Chunk: 16

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part II, Item 2U
Chunk 16
---
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On September 29, 2025, Tvardi issued 1,899 shares of its common stock to a former employee for aggregate proceeds of $11,610.68 pursuant to the exercise of options with an exercise price of $6.1141 per share under Legacy Tvardi’s 2018 Stock Incentive Program. The issuance of such shares was exempt from registration under Rule 701 promulgated under Section 3(b) of the Securities Act. 

​